Skip to main content
UNICEF Logo Europe and Central Asia
  • English
  • русский

Global Links

  • Visit UNICEF Global
  • High contrast
UNICEF Logo Europe and Central Asia
    • EXPLORE UNICEF
      • About us
      • Our mandate
      • Regional Director
      • The situation for children
      • Where we work
      • Our Voices: Young people from the Region
      • Ambassadors and Supporters
      • Partners
  • Press centre

Main navigation Ukrainian language

  • What we do
  • Research and reports
  • Stories
  • Take action
Search area has closed.
Search area has opened.
SearchClose

Search UNICEF

  • Available in:
  • English
  • русский
  • Українська
  • Polish
  • Slovak
  • Hungarian
  • Czech
2 results
  • Article (9)
  • Blog post (2)
  • (-) News note (1)
  • Page (3)
  • Press release (10)
  • Report (3)
  • (-) Statement (1)
  • Armed conflict (1)
  • (-) COVAX (1)
  • COVID-19 (2)
  • (-) Health (0)
  • Humanitarian action and emergencies (1)
  • (-) Immunization (1)
  • (-) Refugee and migrant children (0)
  • (-) Vaccines (2)
  • ECA (1)
  • (-) ECARO (2)
  • Global (6)
Statement
26 April 2021
Celebrating the past, present and future benefits of vaccines
https://www.unicef.org/eca/press-releases/celebrating-past-present-and-future-benefits-vaccines
Copenhagen, Geneva, Brussels, 26 April 2021 - This past, difficult year of the COVID-19 pandemic has made clear how vulnerable we all are to a deadly new disease, when we don’t have the right vaccines or medical technologies we normally use to fight back. Long before COVID-19, one crucial tool – simply called “routine immunization” – was already saving millions of lives and preventing debilitating sickness, particularly among children. Routine immunization protects not only the person vaccinated, but also others in their communities. It helps pave the way to universal health coverage and Goal 3 of the Sustainable Development Goals – ensuring healthy lives and promoting well-being for all at all ages. The roll-out of COVID-19 vaccination at an ever-increasing speed across the WHO European Region, just a year after the start of the pandemic, is an impressive achievement. The European Union, WHO, UNICEF, all national governments and other partners have worked side by side in this response. Thanks to the global COVAX allocation mechanism and Team Europe’s effort some countries in the region that could not have competed on the global vaccine market on their own, are seeing vaccines being rolled-out. The European Union, WHO and UNICEF are now working with private and public sectors to overcome supply and capacity challenges and enable faster delivery. The uneven roll-out of COVID-19 vaccination to date highlights another truth: Inequitable access to health technologies between and within countries hurts us all. The virus and its impact on interlinked economies and societies know no borders. No country is safe until all countries are safe. While COVID-19 vaccination must continue at a faster and more equitable pace, it must not come at the cost of neglecting routine immunization. Any dip in routine coverage caused by the pandemic in 2020 or 2021 will pave the way for future outbreaks and jeopardize decades of progress.   In 2019, the European Region continued its record-breaking trend in routine vaccination coverage rates against measles and other vaccine preventable diseases. While 2020 saw an exceptionally low rate of reported measles cases, the pandemic has challenged national immunization programmes to keep up and catch up on routine shots. We must keep measles and other preventable diseases at bay by maintaining high routine vaccination coverage rates in every community, even during the pandemic. This year, more than ever, we call on everyone to do their part by choosing health information sources carefully, getting all routine vaccinations in due time and accepting COVID-19 vaccination for yourself and your loved ones when your turn comes. Talk to your children and others about vaccination, so they also come to see that it is not just an injection, but an investment in a healthier future and a safer world. A girl is getting her routine vaccination in Armenia. UNICEF Armenia/2021/Margaryan
News note
16 June 2021
UNICEF signs supply agreement for Sputnik V COVID-19 vaccine
https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-sputnik-v-covid-19-vaccine
NEW YORK/COPENHAGEN, 27 May 2021 -  UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF has signed such agreements with the Serum Institute of India, Pfizer and AstraZeneca. Procurement by UNICEF under this agreement is conditional on the product achieving an Emergency Use Listing from WHO, to confirm the quality, safety and efficacy of the vaccine.  In addition, an Advance Purchase Agreement (APA) with Gavi, the Vaccine Alliance, will also be needed for procurement to begin on behalf of the COVAX Facility. Should the COVAX Facility decide to enter into an advance purchase agreement for the supply of the Sputnik V vaccine, UNICEF will be ready to deliver as soon as regulatory milestones have been met. At this point, UNICEF through this LTA, stands ready to access up to 220 million doses of the vaccine available for supply in 2021, to meet country demand.  The Sputnik V vaccine consists of two different components of the vaccine to be administered 21 days apart. An exact delivery schedule will be determined in collaboration with the manufacturer. UNICEF’s priority is to make sure that all countries have safe, fast and equitable access to COVID-19 vaccine and to help them prepare for the rollout of immunization.  The best way to bring the pandemic under control is to ensure that safe and effective vaccines are made available as widely as possible and as quickly as possible, reducing inequity by ensuring that no country or territory is left behind due to its economic status. On 24 February 2021, COVID-19 vaccine vials are produced for the COVAX facility at a manufacturer in Pune, a city located in the western Indian state of Maharashtra. UNICEF/UN0421679?Singh

Footer Ukrainian language

UNICEF Home
  • Situation for children
  • What we do
  • Where we work
Data, Research and Reports
  • Ambassadors and Supporters
  • Partners
  • Publications

Social

Footer secondary Ukrainian language

  • Contact us
  • Legal